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SUMMARY : We have cloned a human T-lymphotropic virus type-1(HTLV-1 ) pro-
viral　 genome, λ 255　 M,　 of　a　cell　 line,　 TL-Su,　 which　 has　 been　 established　 from　 periph-
eral　 blood　 lymphocytes　 of　 a　healthy　 HTLV-1　 carrier.　 The λ 255　M　 had　 a　 very　 similar
restriction　 map　 to　 that　 of　a　previous　 isolate, λ ATK-1,　 but　 a　different　junctional　 re-
peat, TGAAAG, consistent with the random integration sites of HTLV-1. We found 
two species of interesting cellular gene transcripts. The first gene homologous to 
LTR-gag region of HTLV-1 was expressed as 4.5 kb RNA only in the cells of lym-
phoid cell lineage as far as tested. The RNA was present even in uninfected cells in-
cluding a T-cell line, Jurkat, and a B-cell line, FLEB-12-3-4, but not in another T-cell 
line, CEM. Because of strong viral RNA signals, we could not demonstrate the RNA 
in virus producing cell lines. The results suggested the presence of human cellular 
gene related with LTR-gag region of HTLV-1. The other gene homologous to 5' flank-
ing　 gelle　 of　the λ 255　 M　 was　 expressed　 as　 1.8kb　 mRNA　 in　 all　 human　 cells　 tested　 ex-
cept for the TL-Su cell. In the TL-Su cell, HTLV-1 integration modulated this gene 
transcription into 3.8, 3.2. 2.0 and 1.6kb mRNAs qualitatively, and at least 10 times 
more than other human cells quantitatively. The data suggests that HTLV-1 gene in-
tegration may cause the transcriptional modulation of cellular genes by insertional 
mutagenesis. (key words, HTLV-1; HTLV-1 related human gene; transcriptional 
modulation; flanking sequence; insertional mutagenesis )
       INTRODUCTION 
 Human T-lymphotropic virus type-1(HTLV-1) 
is closely associated with adult T-cell leukemia 
(ATL) (Poi sz et al. 198018), HrNuMA et al. 
198139 ~, Yosi-HmA et al. 198260 ), WONG_STAAL 
et al. 198359 ), YosH-DA et al. 198461) ). ATL 
usually develops after age of 40 in HTLV-1 car-
riers (UCH YAMA et al. 197755)), whose infection 
is established early in life mainly via milk of
carrier mothers (HINo et al. 198517), KiNros rA et 
al. 198555)). Chronic development of ATL by 
HTLV-1 is consistent with the absence of typi-
cal oncogene of cellular origin (SEIKI et al. 
198344)). Retroviruses without oncogene may 
cause genetic changes of infected cells leading 
to cellular oncogenesis by 1) promoter /en-
hancer insertional activation (HAYWARD et al. 
198116), PAYrr, et al. 198238), NussE and VARmus 
198235), NussE et al. 198436), NasEN et al.
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198534)), 2)trans-acting transcriptional activa-
tion (INOuE et al. 198620), CROSS et al. 19877 ), 3) 
transduction and subsequent alteration (BISHOP 
et al. 19831), BISHOP, 19842 ), BISHOP and VARMus, 
19843), BISHOP, 19854) ), and 4) insertional inac-
tivation or modulation (VARMus et al. 198156), 
HAWLEYet al. 198215 ), SCHNIEKE et al. 198342 ), 
HARBERS et al.198414), WOLF and ROTTER 198458), 
FRANKELet al. 19859) , KING et al. 198524)). The 
HTLV-1 seems to have no preferential sites for 
the integration (SEMI et al. 198445) ), suggesting 
that the leukemogenesis of ATL is not mediated 
by promoter/enhancer insertional activation of 
an adjacent cellular oncogene as demonstrated 
in avian lymphoma and erythroblastosis in-
duced by avian leucosis virus (ALV) (HAYWARD 
 et al. 198116)). 
  HTLV-1 has a unique pX gene, whose coun-
terpart is not present in type C leukemia viruses 
(SE, Exi et al. 198344) SEIKI et al. 1985a46). HTLV-1 
does not seem to induce ATL by a hit-and-run 
mechanism, since every monoclonal tumor cell 
of ATL contains the HTLV-1 proviral genome, 
at least pX and LTR (YOSHIDA et al . 198461) ). 
Thus, the pX gene has been extensively studied 
as a candidate for responsible gene of leuke-
mogenesis. Recent studies have shown that 
p 40t' encoded by ORFIV (KIYOKAWA et al. 
198426), LEE et al. 198430), MIWA et al. 198431), 
SALMON et al. 198440)) of the pX gene is a trans-
acting transcriptional activator (SODROSI I et al. 
198450), CANN et al. 19855), FELBER et al. 19858), 
FUJISAWA et al. 198612), PAsxALIs et al. 198637), 
SEI'u et al. 198648 ), SHIMOT0HNO et al. 198649 ) 
which promotes transcription from LTR re-
sponding to the enhancer. The p 40 tax also acti-
vates cellular genes, such as interleukin 2 and 
its receptor genes (INouE et al. 198620 ), CROSS 
et al. 19877) ). The activation of these genes 
may be essential to the initial step of transfor-
mation in polyclonal HTLV-1 infected cells. 
Another pX protein, p 27' encoded by ORFIII 
(KIYOKAWA et al. 198527)), has been indicated to 
switch splicing of RNAs, from ones directed to 
early proteins to ones for late proteins, as a 
post-transcriptional modulator of viral RNA 
(INOuE et al. 198721)). However, the conjecture 
may not explain the very low rate and long
incubation period of oncogenic transformation 
among HTLV-1 carrier cells. 
  The transduction and insertional modulation 
models are both related to flanking regions of 
viral genome. To focus on the matter, we ana-
lyzed the flanking region of an HLTV-1 provi-
ral genome in TL-Su cells (SuGAMVRA et al. 
198454)) ; the cell line was established from PBL 
of an HTLV-1 healthy carrier. In this study, we 
found two interesting species of RNAs. One ex-
pressed even in some uninfected cells was ho-
mologous to HTLV-1 LTR-gag region, and the 
other expressed in every human cells tested was 
homologous to 5' flanking region and specifi-
cally modulated in TL-Su cells by HTLV-1 inte-
gration. 
   MATERIALS AND METHODS 
Cells: Table 1 shows the list of cells used in this 
study. Cell lines infected with HTLV-1 include 
MT-2 and MT-4 (MIYosHI et al. 198232), HARADA 
et al. 198513)), TL-OmI (SuGAMURA et al. 198454)) 
and TL-Su. The first cell line was established 
by coculture of peripheral blood lymphocytes 
(PBL) of ATL patients with uninfected cord 
blood cells, while the others by culture of PBL 
of an ATL patient or a carrier, respectively. 
Fresh PBL obtained from a patient with ATL 
(ATLPBL) was prepared by Ficoll-Conray den-
sity gradient centrifugation. At least 70% of 
ATLPBL were leukemic ATL cells by the hema-
tological standard, but they did not express vi-
ral transcripts. The list also includes uninfected 
cell lines originated from T-cell, B-cell, and 
various tumor and non-tumor cells of ectoder-
mal, mesodermal or entodermal origin. We 
added a non-human cell line of bovine origin 
(ENDO). 
 We cultured lymphoid cells in RPMI 1640 
(GIBCO) medium supplemented with 10% fetal 
bovine serum and 2.0 mM L-glutamine, and oth-
er cells in Dulbecco's modified Eagle's MEN 
(GIBCO) supplemented with 5 % fetal bovine 
serum. 
Molecular cloning of HTLV-1 proviral genomes: 
After complete digestion with EcoRI, the high 
molecular weight DNA of TL-Su cells was sized 
with a sucrose density gradient centrifugation . 
The DNA in franctions containing 9-20 kbp
length was ligated to the arms of EMBL-4 phage 
DNA(FurscnAur, et al. 1983]0)), and subjected to 
in vitro packaging (STERNBERG et al. 197753)). 
Approximately 5 X 105 plaques were screened 
with 32P-labelled pATK-33 probe, 2.3 kbp pol 
gene fragment of HTLV-1 genome ( A ATK-1) 
(SEA et al. 198344)). We used a plasmid pUC118 
for subcloning, and pMT-2 /64 /17 containing 
whole HTLV-1 genome as another probe. 
Hybridization analysis: DNA probes were pre-
pared by multi-prime method using 32P-dCTP. 
DNA-DNA hybridization was performed by the 
method of Southern (1975 )52) on nylon mem-
branes (Zeta probe, Biorad) at 42°C for 18 hr in 
a mixture of 50% formamide, 3 X SSPE (1 X 
SSPE: 0.1 M NaCl, 0.01 M sodium phosphate,
pH 7.0), 10% dextran sulfate, I Y6 SDS, 0.5% 
skim milk and 0.2 mg/ml yeast RNA. 
 To analyze cellular RNA,, total cellular RNAs 
were extracted by the procedures of CHIRGWIN 
et al. (1979)6), and poly(A) contaning RNAs 
were isolated by oligo (dT )-cellulose column 
chromatography. The RNAs were fractionated 
by agarose gel electrophoresis in the presence 
of 2.2 M formaldehyde, transferred onto nylon 
membranes, and hybridized at the same condi-
tion as the southern analysis. The filter was 
finally washed at 42 °C for 30 min with a buffer 
of 0.1 x SSC and 0.1% SDS. 
Nucleotide sequence determination: We em-
ployed the method of SANGER et al. (1977)41) for 
the nucleotide sequence analysis.
           Table I. Cells used for Nothern hybridization analysis 
                                        HTLV-1 supplied 
                       origin genome antigens from
TL-Su HTLV-1 carrier + + K. Sugamura 
MT-2 ATLb' + + I. Miyoshi 
MT-4 ATLb) + + I. Miyoshi 
TL-OmI ATL + - K. Sugamura 
ATLPBL fresh ATL cells + - K. Kinoshita 
Jurkat ALL - - H. Shiku 
ELEB 12-3-4 EBVutransformed preB cell - - S. Katamine 
ENDO endothelial cells - - S.A. Aaronson 
T 98 G glioblastoma - - do. 
G 401 Wilm's tumor - - do. 
T 24 bladder carcinoma - - do. 
A 388 epidermoid carcinoma - - do. 
HA 117 GI carcinoma - - do. 
U 937 histiocytic lymphoma - - JCRB-Cell 
a) All cells are originated from human exept ENDO from bovine. 
b) Established by co-cutivation with cord blood lymphocytes. 
c) Epstein-Barr virus.
          RESULTS 
Isolation of A 255M, an HTLV-I proviral ge-
nome: We isolated six independent clones con-
taning HTLV-1 pol gene from a genomic library 
of TL-Su cells, with pATK-33 as a probe. We 
selected A 255M for further analysis, since it 
contained the large enough insert to cover whole 
HTLV-1 genome. Fig 1A shows a simplified re-
striction cleavage map of A 255M. We estimated 
the location of LTRs in comparison to the ge-
netic map of ;L ATK-1. Thirteen restriction sites
of enzymes in A 255M (Fig. 1A) were identical 
to those of A ATK-1, if we estimate the presence 
of approximately 1 kbp deletion in gag pol re-
gion. However, there was some difference be-
tween these two clones, such as the absence of 
Ndel site in the ;L 255M LTR(data not shown). 
The result was consistent with the previous data 
that HTLV-ls isolated in the world are very 
closely related each other, approximately 2 % 
difference in LTR base sequences (WATANABE 
et al. 198457), JosEPxs et al. 198422)) 
 We first subcloned fragments of A 255M, 
p255M-01 through -12, into pUC 118 (Fig. 1A),
Fig. 1. (A) Restriction map of X 255M integrated 
proviral genome of HTLV-1. Thick line 
denotes the location of proviral DNA with a LT 
R (box) at each end. Bottom half shows the map 
of p255M, p255M-01 through -09, and -12 plasmid 
subclones. Restriction site symbols: ®, EcoRI; 
®, Smal; ®,BamHI; 0, PstI; El, HindIIl; O,XbaI; 
*, Hpal. 
(B) Nucleotide sequences of the virus-cellular junc-
tion in the clone ? 255M.
Fig. 2. Northern hybridization analysis of total 
      cellular RNAs by p255M-01 as probe. To-
     tal cellular RNAs, 10 ,u g were appplied
      per lane. Transcript sizes are shown in 
     kilobases. Lanes: 1, ENDO; 2, T98G; 3, 
     G401; 4, T24; 5, A388; 6, HA117; 7, Jurkat; 
      8, FLEB12-3-4; 9, ATLPBL.
and sequenced the junctions of the LTR and 
flanking DNA, which revealed the precise loca-
tion of LTRs and a pair of 6-bp cellular direct 
repeat, TGAAAG, on each external end of the 
LTRs (Fig. 1B). The direct repeat was different 
from the other reported couterparts of HTLV-1 
proviral clones, for example, TAGTTC in case 
of R ATK-1. The result is consistent with the 
previous observations that HTLV-1 integrates 
in a random fashion. From the exact location 
of the junctions, we found that ;t 255M has 
one and seven kbp cellular flanking DNA in the 
5' and 3' ends of the viral genome, respectively. 
Expression of 5' cellular flanking sequences: 
To look for possible expression of flanking se-
quences in human cells, we screened total cellu-
lar RNAs by p255M-01 consisting of the whole 
5' flanking sequences and approximately 4 kbp 
5' end of viral genome as a probe. A northern 
hybridization analysis showed the presence of 
1.8 kb RNA in every human cell tested (Fig. 2) 
except for TL-Su cells (Fig. 3, lane A1) from 
which A 255M was isolated. More interestingly, 
we also found a 4.5 kb RNA in some of the lym-
phoid cells tested (Fig. 2). 
The 4.5 kb RNA homologous to p255M-01: The
Fig. 3. Northern hybridization analysis of total 
     cellular RNAs of TL-Su (lane 1 ), MT-4 
     (lane 2), and Jurkat(lane 3) using p255M 
     -02(A) , -03(B), -04(C), and -09(D) as 
      probes, respectively. Profiles of RNAs of 
      virus producers, TL-Su and MT-4 are not
      shown in (C) because of strong signals of
     viral RNAs. 
4.5 kb RNA was present only in lymphoid cells 
as far as tested, and in uninfected as well as 
infected cells (Fig. 2-4). Of cells positive for the 
4.5 kb RNA, Jurkat and FLEB12-3-4 (KATAmiNE 
et al. 198423)) are unrelated to HLTV-1 in ori-
gin. We confirmed that these cells are negative 
for HTLV-1 by southern and northern hybridi-
zation analyses using pol (pATK-33) or pX
(p255M-09) as probes. None of them was posi-
tive. Fig. 3, Lane D3 shows an example of data 
indicating the absence of any RNA hybridizable 
to pX probe in Jurkat cells. Of HTLV-1 infected 
but not producing cells, TL-OmI (data not 
shown) and ATLPBL (Fig. 2, lane 9) were posi-
tive for the 4.5 kb RNA. However, in cells repli-
cating HTLV-1, such as MT-2, MT-4 and TL-Su, 
we could not identify the presence of the 4.5 kb 
RNA because of the strong viral signals. 
  To localize the sequences with homology, we 
used 3 subclones of p255M-01, EcoRI-HpaI 
(p255M-02), Hpal-Smal (p255M-03) and Smal-
Smal (p255M-04) as probes which correspond 
700 by flanking, 169 by flanking and 31 by LTR 
U3, and most LTR through 50 by 5' end of gag 
gene, respectively. Surprisingly, the 4.5 kb RNA 
did not hybridize with either of the p255M-02 
or p255M-03 probe, i. e. the RNA was not ho-
mologous to the 5' flanking DNA of ;.255M. 
Instead, the 4.5 kb RNA hybridized with the 
p255M-04 (Fig. 3C). The RNA hybridized very 
weakly to p255M-05 probe, but did not to p255M-
06 through -09 (data not shown ). Homology 
of the 4.5 kb RNA and HTLV-1 was confirmed 
by a northern hybridization analysis using 
pMT-2/64/17 as a probe (Fig. 4A). The speci-
ficity of hybridization was high, since more 
stringent wash at 67°C did not remove the sig-
nals (Fig. 4B). Thus, it was clear that 4.5kb 
RNA expressed in certain lymphoid cells is 
transcribed from a cellular gene and related to 
LTR-gag region of HTLV-1. 
The 1.8 kb RNA homologous to p255M-01: To 
localize the sequences homologous to the 1.8 kb 
RNA present in all human cells tested except 
for the TL-Su, we surveyed the 1.8 kb RNA with 
the p255M-02, -03, and -04 as probes. The RNA 
hybridized only with the p255M-02. Poly (A) 
selected RNA showed the same profile suggest-
ing the RNA is mRNA and derived from a gene 
commonly expressed in wide spectrum of cell 
differentiation (Fig. 5) The region of 3' flank-
ing sequence homologous to the 1.8 kb mRNA 
was surveyed with seven subclones covering 
p255M-12 in Fig. 1A, but it was unsuccessful 
because of very strong Alu signals (data not 
shown). 
Nucleotide sequence of 5' cellular flankingDNA: 
To analyze the primary structure of the entire
Fig. 4. Detection of 4.5 kb RNAs using pMT-264'17 
      as a probe. RNA sample, 10 ,ug of each, 
      was applied per lane. A: The filter was 
     washed with 0.1 X SSC, 0.1% SDS at 42°C, 
      B: washed at 67°C. Lanes: 1, TL-Su; 2,MT-
     4; 3, Jurkat; 4, FLEB12-3-4; 5, ATLPBL.
Fig. 5. Northern hybridization analysis of vari-
      ous human cellular RNAs using p255M-02 
     as a probe. Total cellular RNA (10 ,ug 
     each, lane a ) or polyA-selected RNA 
      (1 ,u g each, lane b) was applied. Lanes: 1, 
      TL-Su; 2, MT-4; 3, Jurkat; 4, FLEB12-3-4;
     5, T24; 6, TL-OmI; 7, U937; 8, Rabbit 
      spleen; 9, Mouse spleen.
Fig. 6. Nucleotide sequence of the 5' cellular 
     flanking DNA in .i 255M. Numbering is 
     from the EcoRI site. EcoRI, HpaI, and
      Smal sites are shown by vertical arrows. 
      Underline shows putative exon.
5' cellular flanking region, we determined the 
sequences using fragments of p255M-02 and 03 
by dideoxy chain termination method on both 
strands (Fig. 6). The flanking DNA is extraor-
dinary AT rich (GC content: 30 % ). The se-
quence did not include a typical initation codon 
that conforms reasonably well to Kozak's con-
sensus sequence for 3' splice acceptor site was 
found at nucleotides 559 through 577 ((Py ) >11 
NPyAGG) and 5' splice donor site at nucleotides 
595 through 603 (AAGGTGAGT ) (MourrT 
198233)) . The data implies that the region of pu-
tative exon, the sequence between the splicing 
acceptor and donor sites, hybridized to the 
1.8 kb mRNA in various human cells. Homolo-
gous sequence to this putative exon was not 
found in a data bank, LASL-GDB, release 48.0. 
Modulation of cellular gene expression by inser-
tion of HTLV-1: The TL-Su cell from which 
2. 255M originated was the only human cell not 
expressing the 1.8 kb mRNA, so far as tested. 
However, the cells expressed several species of 
mRNAs hybridizable to the p255M-02, 3.8, 3.2, 
2.0 and 1.6 kb (Fig. 5, Lane 3). Using subfrag-
ments of junctional region (p255M-03) and viral 
genes (p255M-04 to -09) as probes, we tried to 
see if these mRNAs are read through or spliced 
into the viral gene. The excessive expression of 
viral RNA made the analysis difficult. However, 
in short term exposure of these northern blot-
tings, none of these mRNAs hybridizable to 
p255M-02 corresponded with the major viral 
bands(for example, Fig. 3, lanes Al, 131 and D1). 
The results did not exclude the possibility of 
the presence of lower amount of RNA read 
through or spliced into the viral gene. On the 
other hand, as shown in Fig. 5, these mRNAs 
expressed in TL-Su cells are at least 10 times 
more abundant than 1.8 kb mRNA in other cells. 
These results indicated that the flanking cellu-
lar gene adjacent to proviral HTLV-1 genome 
may be qualitatively or quantitatively modu-
lated, or both. 
        DISCUSSION 
 Since HTLV-1 has no oncogene or no specific 
integration site (SEnci et al. 198344), 198445) , 
the function of its unique pX gene has been stud-
ied extensively. However, it seems difficult to 
explain leukemogenesis by the functions of pX
gene alone. On the other hand, it has been well 
known that carcinogens or radiation hit DNA 
in a random fashion, and induce tumors. There-
fore, we are interested in some possible role of 
flanking gene expression modified by integra-
tion of HTLV-1. 
 We cloned HTLV-1 provirus genome from TL-
Su cell line established from PBL: of a healthy 
carrier, and analyzed expression of its flank-
ing DNA in various human cells. In A 255M, the 
proviral genome integrated into a cellular gene 
different from any of previously reported 
HTLV-1 proviral genomes, since 2. 255M had a 
6-bp direct repeat (TGAAAG) on the external 
end of 5' and 3' LTRs, in comparison to A ATM-1 
(CATTCC) (SEan et al. 198243) ), A ATK-1 
(TAGTTC), and pMT-2-42 (GGATAT) (IrNo et 
al. 198619)). 
 Northern hybridization analysis with the 
p255M-01 showed two species of RNA with the 
length of 4.5 and 1.8 kb. The 4.5 kb RNA is ex-
pressed in certain lymphoid cells, such as HTLV-1 
related TL-OmI and ATLPBL and HTLV-1 unin-
fected Jurkat and FLEB12-3-4 cells. However, 
not all lymphoid cells were positive for the 4.5 
kb RNA. For example, neither of an ATL lym-
phoma nor a CD4-positive cell line, CEM, was 
positive (data not shown). None of tested non-
lymphoid cells was positive for the 4.5 kb RNA. 
We failed to define the cell types which express 
the 4.5 kb RNA. In HTLV-1 producers, we could 
not analyze the 4.5 kb RNA because of strong 
signals of viral RNA. 
 The 4.5 kb RNA hybridized to p255M-04 con-
sisted of most LTR through 50 by of gag gene, 
but to p255M-02 consisted of only the flanking 
region of /I 255M. The result strongly suggested 
the presence of a human cellular gene homolo-
gous to HTLV-1 LTR, which may be a target 
of trans-acting transcriptional activation by 
p40t' in HTLV-1 infected cells. Detailed study 
is in progress. 
 The other 1.8 kb RNA was present in all hu-
man cells tested except for TL-Su cells from 
which A255M originated. Since the rabbit and 
mouse spleen cells (Fig. 5) and the bovine cells 
(Fig. 2, lane 1)did not show any RNA hybridi-
zable to the probe, we considered the finding 
to be specific. We fouud 3.8, 3.2, 2.0 and 1.6 kb 
mRNAs in TL-Su cells. Since the 5' flanking
region of 255M contained a splicing donor con-
sensus sequence, these mRNAs transcribed from 
this cellular gene may use unusual splicing ac-
ceptors within the proviral genome. We tried 
to detect these mRNAs species using viral ge-
nome as probe, such as p255M-04 through -09. 
However it was unsuccessful because the ex-
traordinary large amount of viral transcripts 
made it difficult to detect the unusually spliced 
mRNAs. 
 The results suggested that the provirus of 
A 255M integrated within a cellular gene whose 
expression is essential for most cells, although 
we have no information about the biological 
function of the 1.8 kb mRNA. However, the in-
tegration of HTLV-1 qualitatively modulated 
transcription of the gene in TL-Su cells as shown 
by unusual size of 1.8 kb mRNA species In addi-
tion, the same integration quantitatively mod-
ulated transcription of the gene as shown by at 
least 10-f old increase of the 1.8 kb mRNA spe-
cies. The qualitative and/or quantitative modu-
lation of cellular gene expression by HTLV-1 
integration may affect normal cellular functions 
and lead to transformation. 
 On the other hand, oncogenesis is associated 
with recessive mutation rather than activation 
or alteration of genes, such as oncogenes. For 
example, specific chromosomal changes which 
result in homozygosity or hemizygosity for the 
`mutant' or inactive allele are claimed as a key 
mechanism leading to tumor formation, in case 
of retinoblastoma or Wilms' tumor (KNUDSON 
198528)). HTLV-1 integration into one of these 
genes may increase the possibility of malignant 
transformation of human T-cells. In this report, 
we have shown the first evidence of the inser-
tional mutagenesis by HTLV-1 gene integration. 
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